Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular Pathology.
Education
Europe
Masters
Molecular pathology
Standardization
Journal
Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843
Informations de publication
Date de publication:
02 Oct 2024
02 Oct 2024
Historique:
received:
29
06
2024
accepted:
21
09
2024
revised:
26
08
2024
medline:
2
10
2024
pubmed:
2
10
2024
entrez:
1
10
2024
Statut:
aheadofprint
Résumé
Despite advancements in precision medicine, many cancer patients globally, particularly those in resource-constrained environments, face significant challenges in accessing high-quality molecular testing and targeted therapies. The considerable heterogeneity in molecular testing highlights the urgent need to harmonize practices across Europe and beyond, establishing a more standardized and consistent approach in MP laboratories. Professionals, especially molecular pathologists, must move beyond traditional education to cope with this heterogeneity. This perspective addresses critical issues in molecular pathology (MP), such as limited access to high-quality molecular testing, leading to disparities in cancer treatment, and the consequences of inconsistent practices. Recognizing the necessity for a standardized framework for education to address these issues, educational programs play a pivotal role in updating professionals' skills to achieve standardization in MP. European experts from the Steering Committee, the Pathology Section of the European Union of Medical Specialists, and the European Society of Pathology have proposed creating a comprehensive Master's degree program called the "European Masters in Molecular Pathology" (EMMP). This program emerges as a strategic response to the demand for a specialized and standardized framework for education in MP, catering to professionals who concurrently work and study. The program's design aligns with evidence-based education methods, ensuring effective learning and engagement while integrating computational pathology to analyze complex molecular data, enhance diagnostic accuracy, and improve treatment outcomes. EMMP's structured curriculum, strategic partnerships, and regular updates underscore its significance in standardizing MP practices. Exploring future developments, this perspective delves into technology integration and interdisciplinary collaboration, anticipating ongoing advances and harmonization. Challenges and future directions in MP education are discussed, emphasizing the necessity for dynamic curriculum updates, seamless technology integration, and interdisciplinary cooperation. This perspective underscores EMMP's pivotal role in preparing pathologists for this dynamic field, advocating continuous advancements in education and training to uphold excellence in MP practices and maintain the highest patient care standards.
Identifiants
pubmed: 39354109
doi: 10.1007/s00428-024-03933-2
pii: 10.1007/s00428-024-03933-2
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Agence Nationale de la Recherche
ID : ANR-23-IAHU-007
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Mateo J, Steuten L, Aftimos P, Andre F, Davies M, Garralda E et al (2022) Delivering precision oncology to patients with cancer. Nat Med 28:658–665
doi: 10.1038/s41591-022-01717-2
pubmed: 35440717
Akhoundova D, Rubin MA (2022) Clinical application of advanced multi-omics tumor profiling: shaping precision oncology of the future. Cancer Cell 40:920–938
doi: 10.1016/j.ccell.2022.08.011
pubmed: 36055231
Normanno N, Apostolidis K, Wolf A, Al Dieri R, Deans Z, Fairley J et al (2022) Access and quality of biomarker testing for precision oncology in Europe. Eur J Cancer 176:70–77
doi: 10.1016/j.ejca.2022.09.005
pubmed: 36194905
de Jager VD, Timens W, Bayle A, Botling J, Brcic L, Büttner R et al (2024) Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries. Lancet Reg Health - Europe 38:100838
doi: 10.1016/j.lanepe.2024.100838
pubmed: 38476742
Hofman P, Calabrese F, Kern I, Adam J, Alarcao A, Alborelli I et al (2023) Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe. ESMO Open 8:101628
doi: 10.1016/j.esmoop.2023.101628
pubmed: 37713929
pmcid: 10594022
Bruno DS, Hess LM, Li X, Su EW, Patel M (2022) Disparities in biomarker testing and clinical trial enrollment among patients with lung, breast, or colorectal cancers in the United States. JCO Precis Oncol 6:e2100427
doi: 10.1200/PO.21.00427
pubmed: 35737912
Horgan D, Hamdi Y, Lal JA, Nyawira T, Meyer S, Kondji D et al (2023) Empowering quality data - the Gordian knot of bringing real innovation into healthcare system. Diagnosis (Berl) 10:140–157
doi: 10.1515/dx-2022-0115
pubmed: 36548810
Normanno N, Apostolidis K, de Lorenzo F, Beer PA, Henderson R, Sullivan R et al (2022) Cancer biomarkers in the era of precision oncology: addressing the needs of patients and health systems. Semin Cancer Biol 84:293–301
doi: 10.1016/j.semcancer.2021.08.002
pubmed: 34389490
Horgan D, Van den Bulcke M, Malapelle U, Troncone G, Normanno N, Capoluongo ED et al (2024) Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems. Heliyon 10:e23914
doi: 10.1016/j.heliyon.2023.e23914
pubmed: 38234913
Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP et al (2020) Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group. Ann Oncol 31:1491–1505
doi: 10.1016/j.annonc.2020.07.014
pubmed: 32853681
Hendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A et al (2023) Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 34:339–357
doi: 10.1016/j.annonc.2022.12.009
pubmed: 36872130
Horgan D, Hamdi Y, Lal JA, Nyawira T, Meyer S, Kondji D et al (2023) Framework for adoption of next-generation sequencing (NGS) globally in the oncology area. Healthcare (Basel) 11:431
doi: 10.3390/healthcare11030431
pubmed: 36767006
Moulin P, Grunberg K, Barale-Thomas E, der Laak JV (2021) IMI-Bigpicture: a central repository for digital pathology. Toxicol Pathol 49:711–713
doi: 10.1177/0192623321989644
pubmed: 33571073
Matias-Guiu X, Stanta G, Carneiro F, Ryska A, Hoefler G, Moch H (2020) The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology. Virchows Arch 476:491–497
doi: 10.1007/s00428-020-02757-0
pubmed: 32124002
pmcid: 7156353
Stenzinger A, Moltzen EK, Winkler E, Molnar-Gabor F, Malek N, Costescu A et al (2023) Implementation of precision medicine in healthcare-a European perspective. J Intern Med 294:437–454
doi: 10.1111/joim.13698
pubmed: 37455247
Laudadio J, McNeal JL, Boyd SD, Le LP, Lockwood C, McCloskey CB et al (2015) Design of a genomics curriculum: competencies for practicing pathologists. Arch Pathol Lab Med 139:894–900
doi: 10.5858/arpa.2014-0253-CP
pubmed: 26125429
Arcila ME, Snow AN, Akkari YMN, Chabot-Richards D, Pancholi P, Tafe LJ (2022) Molecular pathology education: a suggested framework for primary care resident training in genomic medicine: a report of the Association for Molecular Pathology Training and Education Committee. J Mol Diagn 24:430–441
doi: 10.1016/j.jmoldx.2021.12.013
pubmed: 35304347
Cree IA, Deans Z, Ligtenberg MJ, Normanno N, Edsjo A, Rouleau E et al (2014) Guidance for laboratories performing molecular pathology for cancer patients. J Clin Pathol 67:923–931
doi: 10.1136/jclinpath-2014-202404
pubmed: 25012948
Platonova RI, Orekhovskaya NA, Dautova SB, Martynenko EV, Kryukova NI, Demir S (2022) Blended learning in higher education: diversifying models and practical recommendations for researchers. Frontiers in Education. [Review] 7. https://doi.org/10.3389/feduc.2022.957199
Rangachari D, Im A, Brondfield S (2022) Moving from theory to practice in oncology education when virtual is your reality. Am Soc Clin Oncol Educ Book 42:1–10
pubmed: 35471835
Jang HY, Kim HJ (2020) A meta-analysis of the cognitive, affective, and interpersonal outcomes of flipped classrooms in higher education. Educ Sci 10:115
doi: 10.3390/educsci10040115
Horgan D, Curigliano G, Riess O, Hofman P, Buttner R, Conte P et al (2022) Identifying the steps required to effectively implement next-generation sequencing in oncology at a national level in Europe. J Pers Med 12:72
doi: 10.3390/jpm12010072
pubmed: 35055387
pmcid: 8780351
Horgan D, Bulcke MVD, Malapelle U, Normanno N, Capoluongo ED, Prelaj A et al (2024) Aligning cancer research priorities in Europe with recommendations for conquering cancer: a comprehensive analysis. Healthcare (Basel) 12:259
doi: 10.3390/healthcare12020259
pubmed: 38275541